Emmanuelle Bompas

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Enrollment Status: Active_not_recruiting

Publish Date: December 31, 2024

Intervention Type: Drug

Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone

Study Phase: Phase 3

A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas

Enrollment Status: Active_not_recruiting

Publish Date: December 13, 2024

Intervention Type: Drug, Other

Study Drug: Cabozantinib S-malate

Study Phase: Phase 2

Efficacy of Regorafenib as Maintenance Therapy in Non-adipocytic Soft Tissue Sarcoma Having Received First-line Doxorubicin-based Chemotherapy

Enrollment Status: Completed

Publish Date: December 10, 2024

Intervention Type: Drug

Study Drug: Regorafenib

Study Phase: Phase 2

A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Enrollment Status: Active_not_recruiting

Publish Date: December 05, 2024

Intervention Type: Drug

Study Drug: Regorafenib

Study Phase: Phase 2

Etiosarc: Study of the Environmental Aetiology (Environment, Occupations and Lifestyle) of Sarcomas (Soft Tissue, Visceral and Bone) From a Multicenter French Population-based Case-control Study Among Adults.

Enrollment Status: Completed

Publish Date: November 07, 2024

Intervention Type: Other

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer

Enrollment Status: Active_not_recruiting

Publish Date: September 26, 2024

Intervention Type: Drug

Study Phase: Phase 3

A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.

Enrollment Status: Active_not_recruiting

Publish Date: July 08, 2024

Intervention Type: Drug

Study Drugs: Cobimetinib, Atezolizumab

Study Phase: Phase 1/Phase 2

A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib

Enrollment Status: Completed

Publish Date: June 18, 2024

Intervention Type: Other, Drug

Study Drug: Lenvatinib

Study Phase: Phase 2

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

Enrollment Status: Completed

Publish Date: October 06, 2022

Intervention Type: Drug

Study Drugs: Avapritinib, Regorafenib

Study Phase: Phase 3

NP137 - An Open-label, First in Human, Phase I Trial Aiming to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of a Humanized Monoclonal Antibody Targeting Netrin 1 (NP137) in Patients With Advanced/Metastatic Solid Tumors.

Enrollment Status: Completed

Publish Date: July 25, 2022

Intervention Type: Drug

Study Drug: NP137

Study Phase: Phase 1

A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.

Enrollment Status: Completed

Publish Date: May 09, 2022

Intervention Type: Genetic

Study Phase: Not Applicable

Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study

Enrollment Status: Completed

Publish Date: February 10, 2022

Intervention Type: Drug

Study Drugs: Cabazitaxel, Docetaxel

Study Phase: Phase 2

Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma

Enrollment Status: Terminated

Publish Date: December 30, 2021

Intervention Type: Drug

Study Drug: Optimal TURB

Study Phase: Phase 2

Randomized Phase II Study Evaluating the Feasibility of a Chemotherapy With Docetaxel-Prednisone in a Weekly Schedule or Every 3 Weeks, for Castration-resistant Metastatic Prostate Cancer Elderly Patients (>=75), Vulnerable or Frail , as Defined by the Criteria of the International Society of Geriatric Oncology (SIOG)

Enrollment Status: Completed

Publish Date: June 10, 2021

Intervention Type: Drug

Study Phase: Phase 2

A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02

Enrollment Status: Completed

Publish Date: June 01, 2021

Intervention Type: Drug

Study Drug: Afatinib

Study Phase: Phase 3

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

Enrollment Status: Unknown

Publish Date: May 05, 2021

Intervention Type: Drug

Study Drugs: MK3475, Pembrolizumab, Endoxan, Cyclophosphamide, G100, Metronomic

Study Phase: Phase 2

Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Phase 2 Study

Enrollment Status: Completed

Publish Date: January 20, 2021

Intervention Type: Drug

Study Phase: Phase 2

Phase II Multicenter Study to Determine the Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas

Enrollment Status: Completed

Publish Date: January 31, 2020

Intervention Type: Drug

Study Phase: Phase 2

Overview

Locations

Clinical Research

18 Clinical Trials

112 Total Publications

Areas of Expertise